Prevention of relapse in Category I treated Pulmonary Tuberculosis patients with and without Vitamin D3 supplementatio
Not Applicable
Completed
- Conditions
- Health Condition 1: O- Medical and SurgicalHealth Condition 2: null- Tuberculosis patients-stable
- Registration Number
- CTRI/2021/02/030977
- Lead Sponsor
- Department of Health Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 846
Inclusion Criteria
Age �15 years
Diagnosed PTB CAT I case as per RNTCP guidelines
Able to give informed written consent
Willing to participate in the study
No major medical or surgical illness
Exclusion Criteria
Not willing to participate
Age > 60 years
With major medical or surgical illness
Chronic Alcoholic
Pregnancy &lactation,
On vitamin D and calcium supplementation
On any other drug affecting bone mineral homeostasis during past six months,
Any other clinically overt disease
Body mass index (BMI) < 15.0 kg/m2
Seriously ill patients requiring hospitalization
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To study the effect of vitamin D3 supplementation in the prevention of relapse in category1 (CAT1) treated pulmonary Tuberculosis patientTimepoint: 6 months, 12 months
- Secondary Outcome Measures
Name Time Method Assessment of TB relapse will be done in patients at the end to study periodTimepoint: 3 yrs